Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective is to formulate clinical practice guidelines for treating Cushing's syndrome. PARTICIPANTS: Participants include an Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. The European Society for Endocrinology co-sponsored the guideline. EVIDENCE: The Task Force used the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned three systematic reviews and used the best available evidence from other published systematic reviews and individual studies. CONSENSUS PROCESS: The Task Force achieved consensus through one group meeting, several conference calls, and numerous e-mail communications. Committees and members of The Endocrine Society and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: Treatment of Cushing's syndrome is essential to reduce mortality and associated comorbidities. Effective treatment includes the normalization of cortisol levels or action. It also includes the normalization of comorbidities via directly treating the cause of Cushing's syndrome and by adjunctive treatments (eg, antihypertensives). Surgical resection of the causal lesion(s) is generally the first-line approach. The choice of second-line treatments, including medication, bilateral adrenalectomy, and radiation therapy (for corticotrope tumors), must be individualized to each patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The guidelines provide a general definition of remission after resection of an ACTH-producing corticotroph tumor as morning serum cortisol levels <5 μg/dL (<138 nmol/L) or UFC <28-56 nmol/d (<10-20 μg/d) within 7 days of tumor resection (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Steroidogenesis inhibitors work by inhibiting one or more enzymes involved in steroidogenesis, decreasing cortisol and other steroid hormone production (37, 38).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Available medical therapies currently used in clinical practice to treat CS include medications from 3 classes: pituitary-directed therapies (for pituitary CD only), steroidogenesis inhibitors, and glucocorticoid receptor antagonists (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“In patients with CS, surgical resection of the causative lesion(s) is the first-line treatment option regardless of etiology.”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Pituitary-directed therapies, including pasireotide (US/EU/Canada) and cabergoline (off-label use only), inhibit pituitary ACTH production and, in some cases, ectopic ACTH secretion from neuroendocrine tumors, thereby reducing downstream cortisol secretion (37, 128).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 2×
“(17) 2810 Nieman et al Guidelines on Cushing’s Syndrome Treatment J Clin Endocrinol Metab, August 2015, 100(8):2807–2831”
BackgroundSelf-citationKahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Self-citationPrevention of VTE in Nonorthopedic Surgical Patients
Gould, M. K., Garcia, D. A., Wren, S. M., Karanicolas, P. J., Arcelus, J. I., Heit, J. A., & Samama, C. M. (2012) · Chest · doi:10.1378/chest.11-2297 · Cited by 2,131
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationMolitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Cushing, H. (1964) · Journal of Neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 851
Starkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90079-f · Cited by 840
The natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763
Cited by
Items 801–900 of 1,000
Furman, A. S., & Jialal, I. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0431 · Cited by 2
Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
Kim, D., Cho, Y., Ku, C. R., Jung, H., Moon, J. H., Kim, E. H., Shin, D. Y., Kim, S. H., & Lee, E. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081142 · Cited by 2
Iacobone, M., & Torresan, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-84737-1_19 · Cited by 2
Lopes, M. B., Fonseca, R., Serôdio, J. F., Oliveira, R. P., & Alves, J. D. (2025) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2025.501576 · Cited by 2
Bhansali, A. K., Aggarwal, A., Parthan, G., & Gogate, Y. (2016) · Springer eBooks · doi:10.1007/978-81-322-2815-8_4 · Cited by 2
Surgical treatment of ACTH-ectopic syndrome
Krylov, V. V., Dobreva, E. A., Kharnas, S. S., Kuznetsov, N. S., Marova, E. I., & Levkin, V. V. (2019) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia201908174 · Cited by 2
Resistant hypertension: focus on vascular lesions
Сергеевна, Л. М., Хаишева, Л. А., & Shlyk, S. V. (2020) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2020-1-3-16-26 · Cited by 2
The Management of Neuro-Endocrine Neoplasms
Akirov, A., Amer, L. G., Chbat, J., & Ezzat, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-54391-4_19 · Cited by 2
Ngiam, K. Y., Durand, C., Vasciuc, T. C., Tai, C. H., Orpean, R., Eatock, F., Mahipal, M., & Boon, T. W. (2021) · World Journal of Endocrine Surgery · doi:10.5005/jp-journals-10002-1314 · Cited by 2
Iglesias, T. G., Affeld, M. F., Zúñiga, Á., Olmos, R. I., Baudrand, R. F., & Francisco, I. F. S. (2022) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2021.05.007 · Cited by 2
Functioning metastasis from adrenocortical carcinoma
Cunha, C., Donato, S., Silva, T., & Leite, V. A. P. H. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-246742 · Cited by 2
Sulu, C., KAYNAK, G. K., KÖSKÜN, T., Koca, O., Icli, T. B., Kavla, Y., Özkaya, H. M., Turan, Ş., Eskin, M., & Kadıoğlu, P. (2022) · Pituitary · doi:10.1007/s11102-022-01275-3 · Cited by 2
Moreno-Parro, I., Sánchez, D. O., García‐Moreno, R. M., Rioja, R. G., Martínez, R. F., & Álvarez‐Escolá, C. (2022) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2022-0039 · Cited by 2
Endocrine hypertension in pregnancy
Jebasingh, F., & Thomas, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00004-2 · Cited by 2
Castillo-Huerta, N. M., de la Cruz, J. I. C., Quispe-Gárate, L. A., Lévano-Martínez, M. A., Cabrera, B. M., & Sheen, E. C. (2023) · Surgical Neurology International · doi:10.25259/sni_64_2023 · Cited by 2
Shao, C., Wang, J., Wang, P., & Wu, N. (2023) · Brain Sciences · doi:10.3390/brainsci13040671 · Cited by 2
Challenges and controversies in adrenal surgery: A practical approach
Beninato, T. M., Duh, Q., Long, K. L., Kiernan, C. M., Miller, B. S., Patel, S. G., Randle, R. W., Wachtel, H., Zanocco, K. A., Zern, N. K., et al. (2023) · Current Problems in Surgery · doi:10.1016/j.cpsurg.2023.101374 · Cited by 2
Wang, W., Wang, J. N., Yu, W., Zhu, S. N., Gao, Y., & Zhang, J. Q. (2023) · PubMed Central · doi:10.19723/j.issn.1671-167x.2023.06.017 · Cited by 2
Safe long-term therapy of Cushing’s syndrome over 37 years with mitotane
Seibold, J., Hönemann, M., Tönjes, A., & Sandner, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1294415 · Cited by 2
Castinetti, F., Albarel, F., Cuny, T., Morange, I., Vermalle, M., & Brue, T. C. (2024) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(24)49086-7 · Cited by 2
Trummer, C., Pandis, M., Theiler‐Schwetz, V., Schmitt, L., Obermayer-Pietsch, B. M., Gellner, V., Simon, A., & Pilz, S. (2024) · Endocrine · doi:10.1007/s12020-024-03832-1 · Cited by 2
Fanas, R. L., Goettemoeller, T., Cedeno, K., & Manavalan, A. D. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae128 · Cited by 2
Kargün, S., Aydemir, M., Yılmaz, N., Gürer, İ. E., Sarı, R., & Altunbaş, H. (2024) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_644_22 · Cited by 2
Wernig, J., Pilz, S., Trummer, C., Theiler‐Schwetz, V., Schmitt, L., & Tsybrovskyy, O. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae174 · Cited by 2
Shivnani, P., Kasliwal, R., Goyal, G., Sharma, J., Balani, U., Gupta, P. K., Sharma, B. S., Yadav, D. K., Mishra, V., & Sharma, S. K. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_60_24 · Cited by 2
Bourhila, C., Cotrutz, C., Conti, A., Schiappacasse, L., Levivier, M., & Tuleasca, C. (2025) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2025.111043 · Cited by 2
Small Cell Lung Cancer with Dual Paraneoplastic Syndromes: A Case Report
Song, J., & Fan, L. (2025) · Case Reports in Oncology · doi:10.1159/000542763 · Cited by 2
Long-term cardiometabolic outcomes of primary bilateral macronodular adrenal hyperplasia
Zhou, H., Zhang, P., Yin, Y., Liu, L., Li, J., Xu, H., Yu, F., Su, X., Lyu, Z., Gu, W., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02561-0 · Cited by 2
Saratziotis, A., Baldovin, M., Zanotti, C., Munari, S., Denaro, L., Hajiioannou, J. K., & Emanuelli, E. (2025) · Healthcare · doi:10.3390/healthcare13121395 · Cited by 2
Zhang, C. J., Stein, R., Saleh, M., Wang, P. Z. T., Seemann, N. M., & Babalola, F. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf155 · Cited by 2
Pan, B., Song, Y. J., Kong, X., Xue, Z., & Guo, Y. (1998) · PubMed · Cited by 2
The Challenge of Early Diagnosis of Cushing Disease Recurrence!
Bertherat, J. Y. (2016) · Endocrine Practice · doi:10.4158/ep161600.co · Cited by 2
Cushing’s Disease, Refining the Definition of Remission and Recurrence
Ciporen, J. N., Cetas, J. S., McCartney, S., & Fleseriu, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_12 · Cited by 2
Writers, A. M. (2017) · Drugs & Therapy Perspectives · doi:10.1007/s40267-017-0444-4 · Cited by 2
Optimising pituitary surgery outcomes in Australia: how much does size matter?
McCormack, A. I., & Burt, M. G. (2017) · Internal Medicine Journal · doi:10.1111/imj.13610 · Cited by 2
Cushing’s Syndrome and Glucocorticoid Excess
Koch, C. A. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_28 · Cited by 2
Management of Oral Manifestations in a Case of Cushing\'s Habitus
Panwar, M., & Dias, J. J. (2018) · International Journal of Experimental Dental Science · doi:10.5005/jp-journals-10029-1172 · Cited by 2
Management of glucocorticoids following adrenalectomy for ACTH ‐independent Cushing's syndrome
Seejore, K., & Murray, R. D. (2018) · Clinical Endocrinology · doi:10.1111/cen.13839 · Cited by 2
III. Diagnosis and Management of Cushing Syndrome and Subclinical Cushing Syndrome
Otsuki, M. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.674 · Cited by 2
Adrenocorticotropic Hormon-Secreting Pheochromocytoma: A Rare Cause of Cushing’s Syndrome
Bolayır, B., Okay, D., Aktürk, M., Akın, M., Poyraz, A., Sel, A. T., Yılmaz, B. A., Altınova, A. E., Çakır, N., & Törüner, F. B. (2019) · Endocrinology research and practice. · doi:10.25179/tjem.2018-63374 · Cited by 2
Клинични ползи и финансова тежест на pasireotidе
Камушева, М., Въндева, С., Elenkova, A. P., Zakharieva, S., & Петрова, Г. (2019) · Редки болести и лекарства сираци · doi:10.36865/2019.v10i2.70 · Cited by 2
The Novel Use of Stereotactic Radiotherapy for Remnant Adrenal Tissue in Nelson Syndrome
Martirossian, A. N., Jacob, R., Riley, K. O., Porterfield, J. R., & Vaughan, T. B. (2019) · AACE Clinical Case Reports · doi:10.4158/accr-2019-0333 · Cited by 2
van de Loo, I., & Harbeck, B. (2020) · Springer eBooks · doi:10.1007/978-3-662-58897-0_2 · Cited by 2
Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors
Mathai, C., & Anolik, J. R. (2020) · AACE Clinical Case Reports · doi:10.1016/j.aace.2020.12.002 · Cited by 2
Pituitary Neuroendocrine Neoplasms
Asa, S. L., & Mete, Ö. (2020) · Springer eBooks · doi:10.1007/978-3-030-54391-4_4 · Cited by 2
Multidisciplinary team perspective: A model of care for patients with pituitary tumors
Fountas, A., Hamblin, R., Criseno, S., & Karavitaki, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819949-7.00050-0 · Cited by 2
Sherlock, M., & McDonnell, T. (2021) · Medicine · doi:10.1016/j.mpmed.2021.05.011 · Cited by 2
Zampetti, B., Attanasio, R., Carioni, E., DALLABONZANA, D., Pauna, I., Boniardi, M., & Cozzi, R. C. (2022) · Case Reports in Endocrinology · doi:10.1155/2022/1539203 · Cited by 2
Cushing-szindrómát okozó gyermekkori mellékvesekéreg-adenoma
Bukovszky, B., Gács, Z., Jenővári, Z., Somogyi, D., Micsík, T., Szabó, A., & Sallai, Á. (2022) · Orvosi Hetilap · doi:10.1556/650.2022.32358 · Cited by 2
Non-surgical Interventions for Pituitary Lesions
Suda, N. (2022) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2021.12.004 · Cited by 2
Barkas, K., Barazi, S. A., & Thomas, N. (2017) · Springer eBooks · doi:10.1007/978-3-662-54672-7_13 · Cited by 2
Pregnancy after pituitary surgery does not influence the recurrence of Cushing’s disease
Lousada, L. M., Tapia, M. J. B., Cescato, V. Â. S., da Silva, G. O., Musolino, N. R. D. C., Fragoso, M. C. B. V., Bronstein, M. D., & Machado, M. C. (2022) · Endocrine · doi:10.1007/s12020-022-03151-3 · Cited by 2
Serra, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-19995-0_2 · Cited by 2
White, P. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-06231-5_25 · Cited by 2
ACTH-dependent Cushing's syndrome
Fernandes, S., Varlamov, E. V., & Fleseriu, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00011-x · Cited by 2
Castro, M. A., Berrocal, V. R., Dios, E., Serramito-García, R., Biagetti, B., & Bernabéu, I. (2023) · Neurocirugía (English Edition) · doi:10.1016/j.neucie.2023.07.007 · Cited by 2
Prevalence of endocrine disorders in 304 premenopausal women referred with oligomenorrhoea
Yilmaz, H., Demirpençe, M., Belet, U., Ozkiliç, I., Çolak, A., Ceylan, S., Sarıkaya, M., & Yaşar, E. (2024) · Endokrynologia Polska · doi:10.5603/ep.96737 · Cited by 2
Evaluation and Follow-Up of Patients With Cushing Disease After Pituitary Surgery
Ferrière, A., Cordroch, C., & Tabarin, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64283-6 · Cited by 2
Self-citationSickler, T. D. P. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-08052018-083923 · Cited by 2
Medical Therapy of Hypercortisolism
Feelders, R. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64356-8 · Cited by 2
Long-Term Complications of Hypercortisolism
Pivonello, R., Iacuaniello, D., Simeoli, C., Martino, M. C. D., & Colao, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64305-2 · Cited by 2
Diseases of the pituitary gland
Wojeck, B. S., & Kryger, M. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-65403-6.00044-5 · Cited by 2
New Trends in Treating Cushing’s Disease
Violetis, O., & Alexandraki, K. (2024) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2024.20.2.3 · Cited by 2
Unmasking Hypercortisolism in Difficult-to-Control Type 2 Diabetes: A Useful Paradigm Shift?
Nieman, L. K., & Muniyappa, R. (2025) · Diabetes Care · doi:10.2337/dci25-0038 · Cited by 2
Self-citationControlling cortisol excess and comorbidities in Cushing’s syndrome with osilodrostat
Fleseriu, M., Newell-Price, J. D. C., Gadelha, M. R., & Biller, B. M. K. (2025) · Pituitary · doi:10.1007/s11102-025-01605-1 · Cited by 2
Self-citationHaq, K., Hannouneh, Z. A., Cervantes, C. E., & Hanouneh, M. (2024) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.91a.24002 · Cited by 1
“20 Metyrapone should not be started until all diagnostic evaluations are completed because it may infl uence the results of IPSS.”
PRKAR1A-negative familial Cushing’s syndrome: two case reports
Lim, L., Kitan, N., Paramasivam, S. S., Ratnasingam, J., Ibrahim, L., Chan, S. P., Tan, A. T. B., & Vethakkan, S. R. (2015) · Journal of Medical Case Reports · doi:10.1186/s13256-015-0757-7 · Cited by 1
ACTH measurements in Cushing's syndrome: the need for caution and communication
Qian, S. Y., Smith, J. D., Wijeratne, N. G., & Kevat, D. (2019) · Pathology · doi:10.1016/j.pathol.2019.08.007 · Cited by 1
Durankus, N. K., Samancı, Y., Yılmaz, M., Şengöz, M., Bölükbaşı, Y., & Peker, S. (2022) · Journal of Neurosurgical Sciences · doi:10.23736/s0390-5616.20.05048-1 · Cited by 1
Barrera, F. J., Raygoza-Cortez, K., García-Leal, M., Brito, J. P., Ospina, N. S., & Rodríguez‐Gutiérrez, R. (2021) · Endocrine · doi:10.1007/s12020-020-02592-y · Cited by 1
Modern principles of the diagnosis and conservative treatment of Cushing disease
Abdali, A., Astaf’Eva, L. E., Kalinin, P. L., Trunin, Y., Chernov, I. V., Chmutin, G. E., Abdali, B., Sherzad, G., & Simfukwe, K. (2020) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2010-08 · Cited by 1
The 3PAs syndrome and succinate dehydrogenase deficiency in pituitary tumors
Xekouki, P., Daraki, V. N., Betsi, G., Chrysoulaki, M., Sfakiotaki, M., Mytilinaiou, M. G., & Stratakis, C. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814537-1.00001-4 · Cited by 1
Alexandraki, K., & Grossman, A. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_8 · Cited by 1
Subclinical Cushing’s syndrome: resection of adrenal incidentaloma
Amado, A., Torre, A. P., Graça, S. A. R., & Tavares, A. B. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-247600 · Cited by 1
Elliott, W. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47871-7.00074-5 · Cited by 1
Efficacy of metyrapone for symptoms of adrenocortical carcinoma
Okuda, Y., Kuriyama, T., & Kawamata, T. (2023) · BMJ Supportive & Palliative Care · doi:10.1136/spcare-2023-004233 · Cited by 1
Steroidogenesis inhibitors in the treatment of nonoperative Cushing’s syndrome – a literature review
Kamińska, M., Strzoda, A. J., Strzoda, A., Strzoda, A., Sowiński, W., Zdybel, M., Agata, J. U. D. A., Rojek, K., & Polak, A. (2023) · Family Medicine & Primary Care Review · doi:10.5114/fmpcr.2023.127682 · Cited by 1
Hindré, R., Poté, N., Mordant, P., & Guen, P. L. (2023) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2023.06.007 · Cited by 1
Adrenocorticotropin-Dependent Ectopic Cushing's Syndrome: A Case Report
Matos, A. R., Martins, A., Barbosa, M. J., Quinteiro, I., Faustino, D., Gameiro, R. D. S., & Azevedo, L. (2023) · Cureus · doi:10.7759/cureus.49124 · Cited by 1
Attri, B., Goyal, A., Kalaivani, M., Kandasamy, D., Gupta, Y., Agarwal, S., Shamim, S. A., Damle, N., Sharma, M. C., Jyotsna, V. P., et al. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2236-0864 · Cited by 1
Abouibrahim, M., Rahman, M., Zafar, M., Berliti, S., HACIKURT, K., Dashora, U. K., & Sathiskumar, P. (2024) · Cureus · doi:10.7759/cureus.63619 · Cited by 1
Hannan, C. J., Daousi, C., Radon, M. R., & Gilkes, C. E. (2024) · Operative Neurosurgery · doi:10.1227/ons.0000000000001319 · Cited by 1
Agrawal, N., Sarkar, D., Chatterjee, S., Sinha, P., Bhattacharya, R., Ranjan, P., Chakraborty, P. P., & Bhattacharjee, R. (2024) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/14782715241293817 · Cited by 1
Li, M., Mo, C., Yan, S., Zhao, R., Luo, W., Yang, L., Wang, H., & Hu, J. (2024) · PeerJ · doi:10.7717/peerj.18536 · Cited by 1
IPSS does not impact management in Cushing's Disease when a pituitary tumor is visible on MRI
Lundholm, M. D., Pantalone, K. M., Rao, P. P. R., Hamrahian, A. H., Kshettry, V. R., Recinos, P. F., & Yogi-Morren, D. (2025) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2025.100257 · Cited by 1
Mauro, G. P., Róz, L. M. D., Gico, V. D. C., Weltman, E., de Souza, E. C., Glezer, A., Machado, M. C., Carlotti, C. G., & Villar, R. C. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02646-w · Cited by 1
Desai, R., Sidra, F. N. U., Jia, L., Polanco, P. M., Mutar, S. S. A., & Hamidi, O. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf171 · Cited by 1
Xia, C., Hu, L., Fan, Y., Liu, J., & Gan, Y. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2685-7512 · Cited by 1
Growth hormone deficiency in Cushing’s syndrome: an update on diagnosis and management
Tritos, N. A. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2559673 · Cited by 1
Wu, X. J., Li, X., Peng, H. Y., Wang, P., Xing, S. Z., Liang, L., Wu, B. W., Pan, L. S., Liu, Z. Q., Xie, S., et al. (2025) · Neurosurgical Review · doi:10.1007/s10143-025-03816-3 · Cited by 1
Development and validation of clinical screening systems for Cushing disease in the United States
Salcedo-Sifuentes, J. E., Mehta, S., Suryadevara, C. M., Bergsneider, M., Yuen, K. C. J., Gardner, P. A., Silverstein, J. M., Kim, A. H., Evans, J. J., Barkhoudarian, G., et al. (2025) · Pituitary · doi:10.1007/s11102-025-01583-4 · Cited by 1
Valizadeh, M., Seifi, Z., & Abiri, B. (2025) · Endocrine · doi:10.1007/s12020-025-04452-z · Cited by 1
Ott, M., Bauland, F., Köppl, D., Ayik, A., Geistanger, A., Rauh, M., & Taibon, J. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2025-0522 · Cited by 1
Three Cases of Ectopic, Cyclic Cushing Syndrome: A New Square Wave Variant
Gil, M. M., Tshimbombu, T. N., Ang, Y. L. Y., Rodriguez, M., & Yuen, K. C. J. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf176 · Cited by 1
Arafah, B. M. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf252 · Cited by 1
Ji, B., Lynch, L. K., & Wardlaw, S. L. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf246 · Cited by 1
Bromińska, B., Sawicka‐Gutaj, N., Szczepanek‐Parulska, E., Lange‐Ratajczak, M., Wierzbicki, T., Janicka‐Jedyńska, M., Czepczyński, R., & Ruchała, M. A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1580876 · Cited by 1
Houtz, B. L., Newman, E. D., Cuda, T. L., Kattel, G., Jl, F., & Filippone, E. J. (2025) · Frontiers in Medical Case Reports · doi:10.47746/fmcr.2025.6302 · Cited by 1
Cushing syndrome presenting as persistent delirium
Yu, H., Horsley, P., Wong, S., & Mansour, S. (2025) · Canadian Family Physician · doi:10.46747/cfp.711112719 · Cited by 1
Approach to the Patient with Cushing’s Syndrome: Use of Anticoagulation Therapy
Isand, K., Wass, J. A. H., Karavitaki, N., Fleseriu, M., Klok, F. A., & Pereira, A. M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf671 · Cited by 1
Metadata
- Authors
- Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-08
- Volume
- 100
- Issue
- 8
- Pages
- 2807-2831
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4525003
- OpenAlex
- W2127952551
- Semantic Scholar
- 4d26bfff9a2f2ea132ea661d03d84dc8b2293884
- Cited by
- 1,270
- References
- 213
- Citations by year
- 2026: 99 · 2025: 120 · 2024: 104 · 2023: 117 · 2022: 148 · 2021: 169 · 2020: 116 · 2019: 112 · 2018: 116 · 2017: 83 · 2016: 75 · 2015: 6
- FWCI
- 80.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's syndrome, hypercortisolism, surgical resection, bilateral adrenalectomy, radiotherapy, corticotropinoma, comorbidity management, treatment selection
- MeSH terms
- Adrenal Gland Neoplasms, Adrenalectomy, Cushing Syndrome, Endocrinology, Humans, Patient Care Planning, Pituitary Neoplasms, Recurrence, Remission Induction, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.